MGMT and ovarian carcinoma: The result demonstrated that MGMT promoter methylation was notably correlated with an increased risk of ovarian cancer in the comparison of ovarian cancer patients and normal ovarian tissues (OR = 4.13, 95% CI = 2.32–7.33, p < .001).